A new partnership to support the CAH Community of Pakistan

A new partnership to support the CAH Community of Pakistan

CLAN is grateful to the wonderful team at Pfizer Australia for agreeing to join collaborative efforts to strengthen CLIP (CAH Living In Pakistan), the CAH Community of Pakistan. 

A subsidiary of Pfizer Inc, Pfizer Australia is one of Australia’s leading providers of prescription medicines. A passion for community, respect for people, integrity, innovation, leadership and collaboration are amongst the core values shared by CLAN and Pfizer Australia, and it is on this firm foundational base that we have now agreed to work collaboratively and explore novel opportunities to support children living with Congenital Adrenal Hyperplasia in the Asia Pacific region. 

As the manufacturers of Solu-Cortef (hydrocortisone for injection), Pfizer Australia would be immediately recognizable to virtually the entire CAH Community of Australia… Every family is grateful to Pfizer Australia for producing a drug that we know will save our children’s lives in times of emergency… So how do we help CAH Communities in low- and middle-income countries of the Asia Pacific region experience the same peace of mind?

To date the CAH Community in Pakistan has struggled enormously, with no secure access to affordable hydrocortisone and fludrocortisone tablets; an urgent need for education of families on how to manage sick days and access hydrocortisone injections in emergency situations; limited information on CAH available in Urdu; and a range of other challenges including social discrimination and isolation.

That said, with the successful launch of SPED (the Pakistani Society of Pediatric Endocrinology and Diabetes) in July 2015, there is much to feel optimistic about. It is estimated that there are around 500 children and young people living with CAH in Pakistan, and SPED is now working in partnership with APPES (the Asia Pacific Pediatric Endocrinology Society) and others to drive sustainable change.

Using CLAN’s strategic framework for action, collaborative action for CLIP by a range of parties in 2015-16 promises exciting outcomes, and CLAN is thrilled to have Pfizer Australia join as a key partner.

Thank-you Pfizer Australia!